Masanori Baba
- Infectious Diseases top 0.05%
- Virology top 0.05%
- Molecular Biology top 1%
- Organic Chemistry top 0.5%
- Epidemiology top 0.5%
- Co-authors
- Erik De ClercqRudi PauwelsJan BalzariniPiet HerdewijnShirô ShigetaJan DesmyterDominique ScholsRobert Snoeck
- Topics
- HIV/AIDS drug development and treatment (194 papers)HIV Research and Treatment (170 papers)Immune Cell Function and Interaction (46 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryAngewandte Chemie International Edition
- Partner nations
- JapanBelgiumUnited States
In The Last Decade
Masanori Baba
367 papers receiving 15.6k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Infectious Diseases 6.9k
- Virology 5.9k
- Molecular Biology 5.0k
- Organic Chemistry 3.6k
- Epidemiology 3.3k
Countries citing papers authored by Masanori Baba
This map shows the geographic impact of Masanori Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Baba more than expected).
Fields of papers citing papers by Masanori Baba
This network shows the impact of papers produced by Masanori Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Baba. The network helps show where Masanori Baba may publish in the future.
Co-authorship network of co-authors of Masanori Baba
This figure shows the co-authorship network connecting the top 25 collaborators of Masanori Baba. A scholar is included among the top collaborators of Masanori Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanori Baba. Masanori Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | 17 | |
| 4 | Immunomodulatory Potential of Herbal Formulations Containing Seeds of Nigella sativa Linn. | 1 |
| 5 | 5 | |
| 6 | Synergistic inhibition of HTLV-1-infected cell proliferation by combination of cepharanthine and a tetramethylnaphthalene derivative. | 14 |
| 7 | 4 | |
| 8 | 18 | |
| 9 | 14 | |
| 10 | 178 | |
| 11 | 7 | |
| 12 | 26 | |
| 13 | 2 | |
| 14 | 34 | |
| 15 | 12 | |
| 16 | Anti-AIDS drug development : challenges, strategies, and prospects | 12 |
| 17 | 125 | |
| 18 | Highly potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by the HIV-1-specific reverse transcriptase inhibitors | 13 |
| 19 | 76 | |
| 20 | 0 |
About Masanori Baba
Masanori Baba is a scholar working on Virology, Infectious Diseases and Immunology, having authored 372 papers that have together received 16.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (194 papers), HIV Research and Treatment (170 papers) and Immune Cell Function and Interaction (46 papers). The work is most often cited by research in Virology (5.9k citations), Infectious Diseases (6.9k citations) and Immunology (3.2k citations). Masanori Baba has collaborated with scholars based in Japan, Belgium and United States. Frequent co-authors include Erik De Clercq, Rudi Pauwels, Jan Balzarini, Piet Herdewijn, Shirô Shigeta, Jan Desmyter, Dominique Schols, Robert Snoeck, Mika Okamoto and Mitsuru Akashi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.